These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10984969)

  • 1. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 2000 Aug; 10(34):309-10. PubMed ID: 10984969
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 1999 Aug; 9(35):317-8. PubMed ID: 10506800
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 2000 Nov; 10(44):399-400. PubMed ID: 11103480
    [No Abstract]   [Full Text] [Related]  

  • 5. Interventions with drug injectors in the UK: trends in risk behaviour and HIV prevalence.
    Stimson GV; Hunter G
    Int J STD AIDS; 1996; 7 Suppl 2():52-6. PubMed ID: 8799796
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS and HIV-1 infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 1996 Apr; 6(16):141-4. PubMed ID: 8722611
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
    Wylie JL; Shah L; Jolly AM
    BMC Public Health; 2006 Sep; 6():229. PubMed ID: 16970811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 1999 Nov; 9(48):431-3. PubMed ID: 10592652
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
    Estrada AL
    Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S126-34. PubMed ID: 12435836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drug injectors' strategies for cleaning needles and syringes: findings from qualitative research.
    Hughes R
    Scand J Public Health; 2000 Jun; 28(2):158-60. PubMed ID: 10954144
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 1997 Apr; 7(17):153-6. PubMed ID: 9534821
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS and HIV infection in the United Kingdom: monthly report.
    Commun Dis Rep CDR Wkly; 2000 Mar; 10(13):123-4. PubMed ID: 10777996
    [No Abstract]   [Full Text] [Related]  

  • 14. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of health care workers exposed to bloodborne viruses at work: July 1997 to June 2000.
    Commun Dis Rep CDR Wkly; 2000 Aug; 10(33):293. PubMed ID: 10979615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV epidemiology and interventions among injecting drug users.
    Des Jarlais DC; Friedman SR
    Int J STD AIDS; 1996; 7 Suppl 2():57-61. PubMed ID: 8799797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
    Hillgren K; Sarkar K; Elofsson S; Britton S
    Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs).
    Nordén L; Lidman C
    Scand J Infect Dis; 2005; 37(6-7):493-6. PubMed ID: 16012010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
    Reynolds GL; Fisher DG; Napper LE
    J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.